Mary Anna Venneri

Pubblicazioni

Titolo Pubblicato in Anno
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy CANCERS 2023
Gender-Specific Impact of Sex Hormones on the Immune System INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection PATHOGENS 2023
Cellular immune profiling of lung and blood compartments in patients with SARS-CoV-2 infection PATHOGENS 2023
Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Pituitary adenoma consistency affects postoperative hormone function: a retrospective study BMC ENDOCRINE DISORDERS 2023
The Diagnostic Potential of the Human Blood Microbiome: Are We Dreaming or Awake? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia CANCERS 2023
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors JOURNAL OF TRANSLATIONAL MEDICINE 2023
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM study INTERNATIONAL JOURNAL OF OBESITY 2023
Correction: Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM study INTERNATIONAL JOURNAL OF OBESITY 2023
Human genital tracts microbiota: dysbiosis crucial for infertility JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders THERANOSTICS 2022
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial SCIENCE TRANSLATIONAL MEDICINE 2022
The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2022
cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor FRONTIERS IN ENDOCRINOLOGY 2022
Revisiting the physiological role of androgens in women EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM 2022
Ketogenic Diet Increases Serum and White Adipose Tissue SIRT1 Expression in Mice INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022

ERC

  • LS4
  • LS4_4
  • LS4_9

Interessi di ricerca

Sviluppo di modelli preclinici in vitro (colture 2D, 3D, co-colture) e in vivo (modelli murini transgenici,
knock-in/knock-out) per lo studio dei meccanismi coinvolti nello sviluppo e nella progressione delle
patologie immuno-metaboliche (es. Diabete, Obesità) e l’identificazione di bersagli terapeutici e
marcatori molecolari. Studio del cross-talk tra le cellule immunitarie, endoteliare e vascolari per lo
sviluppo di approcci terapeutici innovativi (target therapies). Immuno-phenotyping per la
caratterizzazione delle cellule circolanti (PBMCs) derivate da pazienti. Studio degli effetti degli
interferenti endocrini sul sistema endocrino-metabolico. Studio degli effetti delle alterazioni del
sistema circadiano sul sistema immuno-metabolico.

Keywords

acute and chronic inflammation diseases
diabetes and metabolism
endocrine disorders

Gruppi di ricerca

Gruppi di ricerca - Responsabile

Laboratori di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma